Michaela Levin

Michaela Levin is an experienced biotech business development leader with a strong track record, including multiple billion-dollar mergers and acquisitions. They have held notable positions at institutions such as Partners HealthCare, where they managed significant portfolios and led licensing negotiations, and Ovid Therapeutics, where they closed deals valued over $150 million. Michaela's academic background includes a PhD in Neuroscience from the University of Virginia, where their research focused on the biophysical properties of potassium ion channels in the inner ear. Currently, they serve as Vice President of Business Development at Recursion and Exscientia, driving strategic collaborations and licensing opportunities in oncology and rare diseases.